TY  - JOUR
AU  - Navarro-Gonzalez, Elena
PY  - 2022
DO  - 10.1002/cam4.4983
UR  - http://hdl.handle.net/10668/21063
T2  - Cancer medicine
AB  - Bone is the second most common distant metastasis site in differentiated thyroid cancer (DTC) and is normally associated with the presence of other metastases, which are usually radioiodine-resistant. The presence of bone metastasis (BM) determines...
LA  - en
KW  - bisphosphonates
KW  - bone metastases
KW  - denosumab
KW  - lenvatinib
KW  - multikinase inhibitors
KW  - radioiodine-refractory thyroid cancer
KW  - Adenocarcinoma
KW  - Antineoplastic Agents
KW  - Bone Neoplasms
KW  - Humans
KW  - Iodine Radioisotopes
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Quinolines
KW  - Retrospective Studies
KW  - Thyroid Neoplasms
TI  - Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine-resistant differentiated thyroid cancer.
TY  - research article
VL  - 11 Suppl 1
ER  -